REQUEST A DEMO
Total
USD $0.00
Search more companies

Merck Serono SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Corporate, Subsidiary, and Regional Managing Offices
Full name: Merck Serono SIA Profile Updated: July 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Merck Serono SIA is based in Latvia. The head office is in Riga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on June 27, 2009. 16 (2023) employees currently work for Merck Serono SIA. From the latest financial highlights, Merck Serono SIA reported a net sales revenue increase of 11.3% in 2025. During that time, Merck Serono SIA’s total assets grew by 20.91%. In, 2025, the company’s net profit margin increased by 0.71%.

Headquarters
Duntes iela 23A
Riga; Riga; Postal Code: 1005

Contact Details: Purchase the Merck Serono SIA report to view the information.

Website: http://www.merck.lv

Basic Information
Total Employees:
Purchase the Merck Serono SIA report to view the information.
Registered Capital:
Purchase the Merck Serono SIA report to view the information.
Financial Auditors:
Purchase the Merck Serono SIA report to view the information.
Incorporation Date:
June 27, 2009
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Merck Serono SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.3%
Total Operating Revenue
3.33%
Operating Profit
37.6%
Net Profit/Loss for the Period
37.01%
Total Assets
20.91%
Total Equity
6.81%
Operating Profit Margin
0.8%
Net Profit Margin
0.71%
Return on Equity (ROE)
1.41%
Quick Ratio
-4.3%
Cash Ratio
-0.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?